Measles Vaccine Virus RNA in Children More Than 100 Days after Vaccination

Measles Vaccine Virus RNA in Children More Than 100 Days after Vaccination

Measles vaccines have been in use since the 1960s with excellent safety and effectiveness profiles. Limited data are available on detection of measles vaccine virus (MeVV) RNA in human subjects following vaccination. Available evidence suggests MeVV RNA can be identified up to 14 days after vaccinat...

Full description

Bibliographic Details
Main Authors:	Jamie McMahon, Ian M Mackay, Stephen B Lambert
Format:	Article
Language:	English
Published:	MDPI AG 2019-07-01
Series:	Viruses
Subjects:	measles vaccine measles virus vaccines measles RT-PCR vaccine safety measles-mumps-rubella RNA persistence
Online Access:	https://www.mdpi.com/1999-4915/11/7/636

Similar Items

Post Vaccine Rubella During a Measles Outbreak: Clinical Case
by: Luísa Graça, et al.
Published: (2021-02-01)

Determinants of Equity in Coverage of Measles-Containing Vaccines in Wales, UK, during the Elimination Era
by: Malorie Perry, et al.
Published: (2023-03-01)

Differential Demographic and Clinical Characteristics between MMR Vaccinated and Unvaccinated Children in South Korea: A Nationwide Study
by: Dongwon Yoon, et al.
Published: (2021-06-01)

Previous vaccination modifies both the clinical disease and immunological features in children with measles
by: Mitchell P, et al.
Published: (2013-06-01)

Two cases of measles after vaccination with measles mumps and rubella combined live attenuated vaccine
by: SHEN Jinhua, et al.
Published: (2022-05-01)

Utility of serological screening for measles, mumps and rubella in immunocompromised patients
by: L Sticchi, et al.
Published: (2019-12-01)

Immune-Response of Individuals after Immunization with Rubella Vaccine
by: Layla Fouad Ali
Published: (2011-12-01)

Immunogenicity after outbreak response immunization activities among young healthcare workers with secondary vaccine failure during the measles epidemic in Korea, 2019
by: Hyeri Seok, et al.
Published: (2022-06-01)

Vaccine-associated measles in a patient treated with natalizumab: a case report
by: Alix Miauton, et al.
Published: (2020-10-01)

Two-year antibody persistence in children vaccinated at 12–15 months with a measles-mumps-rubella virus vaccine without human serum albumin
by: Andrea A. Berry, et al.
Published: (2017-07-01)

Epidemiological study to assess the status of measles vaccination in under five children and factors associated, in a peri-urban area, Asudgaon village, in Raigad district, Maharashtra, India
by: Neha Riswadkar, et al.
Published: (2022-01-01)

Ongoing Measles Outbreak in Orthodox Jewish Community, London, UK
by: Vanessa Baugh, et al.
Published: (2013-10-01)

Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart
by: Abbas Zamanian, et al.
Published: (2014-01-01)

Profiling of Measles-Specific Humoral Immunity in Individuals Following Two Doses of MMR Vaccine Using Proteome Microarrays
by: Iana H. Haralambieva, et al.
Published: (2015-03-01)

Immunogenicity of Viral Vaccines in the Italian Military
by: Claudia Ferlito, et al.
Published: (2021-01-01)

Intralesional Injection of the Measles–Mumps–Rubella Vaccine into Resistant Palmoplantar Warts: A Randomized Controlled Trial
by: Mohammad Sadegh Rezai, et al.
Published: (2019-01-01)

Epidemiological changes in measles infections in southern China between 2009 and 2016: a retrospective database analysis
by: Huizhen Zheng, et al.
Published: (2020-03-01)

Mitigating Vaccine Hesitancy and Building Trust to Prevent Future Measles Outbreaks in England
by: Sarah Thompson, et al.
Published: (2023-01-01)

Severe pneumococcal pneumonia following Measles- Mumps- Rubella vaccination / Pneumonie pneumococică severă dezvoltată ca urmare a vaccinării Rujeolă-Oreion-Rubeolă
by: Gál Orsolya, et al.
Published: (2016-09-01)

A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
by: Manlio Fusciello, et al.
Published: (2022-06-01)

Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina
by: Carla Vizzotti, et al.
Published: (2023-03-01)

Safety, immunogenicity and non-interference of concomitant Typhoid Vi capsular polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV®) and measles or measles-mumps-rubella vaccines in 8–9 months-old Indian children
by: Krishna Mohan Vadrevu, et al.
Published: (2022-12-01)

Factors associated with mumps meningitis and the possible impact of vaccination
by: Kyuyol Rhie, et al.
Published: (2016-01-01)

Waning immunity of one-dose measles-mumps-rubella vaccine to mumps in children from kindergarten to early school age: a prospective study
by: Yuanbao Liu, et al.
Published: (2018-05-01)

Vaccine Effectiveness Estimates, 2004–2005 Mumps Outbreak, England
by: Cheryl Cohen, et al.
Published: (2007-01-01)

Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study
by: The MMR-162 Study Group
Published: (2018-12-01)

Are the Objectives Proposed by the WHO for Routine Measles Vaccination Coverage and Population Measles Immunity Sufficient to Achieve Measles Elimination from Europe?
by: Pedro Plans-Rubió
Published: (2020-05-01)

A challenging modified measles outbreak in vaccinated healthcare providers
by: Omar Zmerli, et al.
Published: (2021-03-01)

Measles immunity gap among reproductive-age women participating in a simulated HIV vaccine efficacy trial in Zambia
by: Kalonde Malama, et al.
Published: (2022-11-01)

Early protection against measles infection in children Immunized with DPT-measles Vaccine at the Age of 4 Months
by: Soegeng Soegijanto, et al.
Published: (2018-12-01)

Determination of ELISA reactive mumps IgG antibodies in MMR vaccine recipients in comparison with MMR vaccine naive children: A cross sectional study
by: Gupta Riya, et al.
Published: (2021-01-01)

The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: A retrospective cohort study
by: Giuseppe La Torre, et al.
Published: (2017-08-01)

Evaluation of anti-measles and anti-mumps vaccination coverage in a cohort of youth in South-Centre of Sicily, Italy
by: Claudia Lo Magno, et al.
Published: (2015-12-01)

Thoughts, beliefs and concepts concerning infectious childhood diseases of physicians practicing homeopathic, anthroposophic and conventional medicine – a qualitative study
by: N. Mittring-Junghans, et al.
Published: (2021-01-01)

Overview of aseptic meningitis after MMR vaccination in a group of Iranian infants in Children’s Medical Center
by: Parisa Rahmani, et al.
Published: (2020-10-01)

A National Survey to Evaluate Measles-Rubella National Vaccination Campaign Coverage in Egypt
by: Amr Kandil, et al.
Published: (2019-04-01)

Measles: A disease that’s making a comeback
by: Małgorzata Bojarska, et al.
Published: (2022-08-01)

efficacy of measles vaccine in study among primary school children during measles outbreak in Iraqi for the year 2004
by: sana a Muhammed Hussian Alizi, et al.
Published: (2008-04-01)

Evaluation of vaccination coverage of measles-rubella campaign in Imphal East District, Manipur: A cross-sectional study
by: Bishwalata Rajkumari, et al.
Published: (2020-01-01)

External rapid convenience monitoring of measles–rubella campaign 2017 and lessons learned: Study from a hilly district of North India
by: Devender Kumar, et al.
Published: (2020-01-01)